Search Results - "AGARWAL, Roshan"

Refine Results
  1. 1

    Ovarian cancer: strategies for overcoming resistance to chemotherapy by Agarwal, Roshan, Kaye, Stan B

    Published in Nature reviews. Cancer (01-07-2003)
    “…Ovarian cancer is responsible for 4% of deaths from cancer in women. Treatment comprises a combination of surgery and chemotherapy, but patients typically…”
    Get full text
    Journal Article
  2. 2

    EMA/CO for High-Risk Gestational Trophoblastic Neoplasia: Good Outcomes With Induction Low-Dose Etoposide-Cisplatin and Genetic Analysis by ALIFRANGIS, Constantine, AGARWAL, Roshan, SHORT, Delia, FISHER, Rosemary A, SEBIRE, Neil J, HARVEY, Richard, SAVAGE, Philip M, SECKL, Michael J

    Published in Journal of clinical oncology (10-01-2013)
    “…Patients with high-risk (International Federation of Gynecology and Obstetrics score ≥ 7) gestational trophoblastic neoplasia (GTN) frequently receive…”
    Get full text
    Journal Article
  3. 3

    Mechanisms of transcoelomic metastasis in ovarian cancer by Tan, David S P, Agarwal, Roshan, Kaye, Stanley B

    Published in The lancet oncology (01-11-2006)
    “…Metastasis from epithelial ovarian cancer can occur via the transcoelomic, haematogeneous, or lymphatic route. Of these, transcoelomic metastasis is the most…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT by Wu, Olivia, McCartney, Elaine, Heggie, Robert, Germeni, Evi, Paul, James, Soulis, Eileen, Dillon, Susan, Ryan, Caoimhe, Sim, Moira, Dixon-Hughes, Judith, Agarwal, Roshan, Bodenham, Andrew, Menne, Tobias, Jones, Brian, Moss, Jonathan

    “…Venous access devices are used for patients receiving long-term chemotherapy. These include centrally inserted tunnelled catheters or Hickman-type devices…”
    Get full text
    Journal Article
  6. 6

    DNA-PK Mediates AKT Activation and Apoptosis Inhibition in Clinically Acquired Platinum Resistance by Stronach, Euan A, Chen, Michelle, Maginn, Elaina N, Agarwal, Roshan, Mills, Gordon B, Wasan, Harpreet, Gabra, Hani

    Published in Neoplasia (New York, N.Y.) (01-11-2011)
    “…Abstract Clinical resistance to chemotherapy is a frequent event in cancer treatment and is closely linked to poor outcome. High-grade serous (HGS) ovarian…”
    Get full text
    Journal Article
  7. 7

    Chemotherapy and human chorionic gonadotropin concentrations 6 months after uterine evacuation of molar pregnancy: a retrospective cohort study by Agarwal, Roshan, MRCP, Teoh, Suliana, MRCP, Short, Delia, BSc, Harvey, Richard, PhD, Savage, Philip M, FRCP, Seckl, Michael J, Prof

    Published in The Lancet (British edition) (2012)
    “…Summary Background Indications for chemotherapy in gestational trophoblastic disease include raised human chorionic gonadotropin (hCG) concentrations 6 months…”
    Get full text
    Journal Article
  8. 8

    Androgen Receptor Levels and Association with PIK3CA Mutations and Prognosis in Breast Cancer by GONZALEZ-ANGULO, Ana M, STEMKE-HALE, Katherine, MILLS, Gordon B, HENNESSY, Bryan T, PALLA, Shana L, CAREY, Mark, AGARWAL, Roshan, MERIC-BERSTAM, Funda, TRAINA, TiffanyA, HUDIS, Clifford, HORTOBAGYI, Gabriel N, GERALD, William L

    Published in Clinical cancer research (01-04-2009)
    “…Purpose: To examine the androgen receptor (AR) levels in breast cancer and to assess the impact of AR expression on patient outcomes. Experimental Design:…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Emerging Role of the RAB25 Small GTPase in Cancer by Agarwal, Roshan, Jurisica, Igor, Mills, Gordon B, Cheng, Kwai Wa

    Published in Traffic (Copenhagen, Denmark) (01-11-2009)
    “…RAB25, a member of the rat sarcoma (RAS) family of small GTPase, has been implicated in the pathophysiology of ovarian, breast and other cancers. Its role in…”
    Get full text
    Journal Article
  11. 11

    Central Giant Cell Granuloma of the Mandible: A Case Report by Desai, Ojas V, Kshirsagar, Rajesh, Singh, Vikram, Nair, Vivek S, Sane, Vikrant, Jain, Saurabh, Agarwal, Roshan

    Published in Curēus (Palo Alto, CA) (06-04-2024)
    “…This article presents a clinical case of a central giant cell granuloma (CGCG) resembling a periapical lesion of endodontic origin. A 39-year-old, otherwise…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Autotaxin delays apoptosis induced by carboplatin in ovarian cancer cells by Vidot, Susanne, Witham, James, Agarwal, Roshan, Greenhough, Sebastian, Bamrah, Harnoor S., Tigyi, Gabor J., Kaye, Stanley B., Richardson, Alan

    Published in Cellular signalling (01-06-2010)
    “…Drug resistance remains a barrier to the effective long term treatment of ovarian cancer. We have established an RNAi-based screen to identify genes which…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Malignant Ovarian Germ Cell Tumors: Identification of Novel Prognostic Markers and Long-Term Outcome After Multimodality Treatment by MURUGAESU, Nirupa, SCHMID, Peter, DANCEY, Gairin, AGARWAL, Roshan, HOLDEN, Lydia, MCNEISH, Lain, SAVAGE, Philip M, NEWLANDS, Edward S, RUSTIN, Gordon J. S, SECKL, Michael J

    Published in Journal of clinical oncology (20-10-2006)
    “…Malignant ovarian germ cell tumors are rare and knowledge about prognostic parameters currently is limited. This study was undertaken to evaluate long-term…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Eligibility of patients with brain metastases for phase I trials: time for a rethink? by Carden, Craig P, FRACP, Agarwal, Roshan, MRCP, Saran, Frank, Prof, Judson, Ian R, Prof

    Published in The lancet oncology (01-10-2008)
    “…Summary Since the inception of phase I clinical trials in cancer, patients with symptomatic brain metastases have commonly been excluded from participation…”
    Get full text
    Journal Article
  19. 19

    Transient ectopic expression as a method to detect genes conferring drug resistance by Witham, James, Vidot, Susanne, Agarwal, Roshan, Kaye, Stanley B., Richardson, Alan

    Published in International journal of cancer (01-06-2008)
    “…Ectopic expression provides an alternative to RNAi to conduct functional genomic screens. We have determined whether transient expression can be used to…”
    Get full text
    Journal Article
  20. 20